iSectra — Believe IT
Pharmaceutical

What Downtime Actually Costs When You're Manufacturing

In a regulated manufacturing environment the cost of an outage is rarely the lost hours — it's the deviation, the investigation, and the product disposition question that outlives the outage by months. What specifically breaks, and what it takes to put it right.

Santiago Aristizabal Sep 16, 2026 8 min read
What Downtime Actually Costs When You're Manufacturing

In a regulated manufacturing environment the cost of an outage is rarely the lost hours — it is the deviation it creates, the investigation that deviation requires, and the question it raises about product disposition that can outlive the outage by months. The money is in the quality work that follows, not the idle time.

I run IT environments for pharmaceutical manufacturers. What follows is the conversation I have with COOs and CFOs who have asked their IT provider for an uptime number and received a percentage that tells them nothing about what actually happens when a system goes down. It is not about availability. It is about what specifically breaks and what it takes to put it right.

Pharma IT Readiness Assessment

See where your regulated environment actually stands.

Fifteen questions, about five minutes, scored on screen with a remediation roadmap emailed to you.

Take the assessment

Why is this different from ordinary business downtime?

In most businesses an outage costs productivity — people sit idle, work resumes later, and the loss is measured in hours. In regulated manufacturing, a process that was being monitored and recorded stopped being monitored and recorded, and that gap is itself the problem. The record is part of the product.

Under cGMP, a manufacturer must be able to show that a product was made under controlled conditions and that those conditions were maintained throughout. 21 CFR Part 211 sets out the requirements for production, laboratory, and records controls for finished pharmaceuticals. When a system that captures a critical parameter goes down, the question is not "when can we restart" but "do we have a continuous record for the period we were down, and if not, what does that mean for the batch." An IT outage in this context is a manufacturing event, not an IT event — and it gets handled by quality, not by the help desk.

What actually stops?

Be concrete rather than abstract. When the systems that support manufacturing go down, several things fail in different ways:

  • Environmental monitoring and building management. Temperature, humidity, and pressure differentials in controlled areas stop being recorded. The room may still be within spec, but the record showing it was within spec has a gap.
  • Batch record systems. Electronic batch records become inaccessible, or the systems supporting paper batch records — label printers, weighing stations, review stations — stop working. Operators cannot execute or record the steps in the sequence.
  • Laboratory instruments and LIMS. Instruments that generate raw data stop capturing it, or the laboratory information system stops receiving it. A chromatography run that completes but cannot be recorded is a data gap, not a result.
  • Warehouse and materials management. Receipt, sampling, and release of materials and components stall. The system that prevents an untested component from being issued to manufacturing is not enforcing that control.
  • Label printing and serialization. Packaging lines stop because labels cannot be printed or verified, or serialization data cannot be exchanged with the track-and-trace system.
  • Access control to controlled areas. Badge readers stop working, and the question becomes whether people can enter controlled areas safely and whether their entry was logged.

What each one failing means in practice is different. Some create a data gap that quality must assess. Others stop production outright. The point is that the consequence is not "people wait" — it is a specific regulatory question about a specific record.

What happens to the batch?

This is the section that makes the argument. A gap in monitoring data is a deviation. Under cGMP, a deviation requires investigation, root cause determination, an impact assessment, and a documented disposition decision — release, reject, or hold pending further evaluation.

The batch is not automatically lost. Many gaps are recoverable: a redundant sensor captured the same parameter, or a manual reading was taken at the right interval, or the gap falls outside a critical window and quality can justify release with documented rationale. But determining whether the batch is sound takes quality time, sometimes additional testing, and always documentation. The investigation has to show what happened, why, what was affected, and what prevents it from recurring. That work is the real cost of the outage, and it can take days or weeks to close — long after the system itself was restored.

FDA's data integrity guidance is explicit that CGMP records must be complete, consistent, and accurate, and that data must be preserved throughout the retention period. A gap where data was never captured is a data integrity question, and data integrity questions are treated seriously because they go to whether the record can be relied upon at all.

What does the paperwork actually cost?

This is where the real expense sits, and it is the part an IT provider quoting an uptime percentage will never mention. Deviation investigation and corrective and preventive action consume quality resource that was allocated elsewhere. A quality engineer who was closing out a process validation now spends a week investigating an IT outage instead. The opportunity cost is real and rarely tracked.

The record persists. A deviation investigation becomes part of the quality system and will be reviewed at the next inspection — as investigators look at the state of your IT systems and the deviations they generated. A single availability-related deviation is a document. A pattern of them becomes a question about the state of control — whether the facility is operating in a controlled, reproducible condition or lurching from incident to incident. That is a much larger conversation than the original outage, and it is the conversation a COO does not want an inspection to open.

What about clinical and commercial supply?

Widen it beyond the plant. An outage that delays release testing holds up shipment — a clinical supply that was due at a site does not arrive. Cold chain monitoring interruptions raise a question about whether temperature-sensitive material stayed within range during the gap. Where a company supplies a clinical trial, a supply interruption reaches patients and sponsors, not just a P&L. A missed dose window in a trial is not a commercial inconvenience; it is a protocol question, and protocol questions reach the sponsor and the IRB.

The cost here is not just the hours of delay. It is the communication, the justification, and the remediation that a sponsor or a clinical site requires. A single delayed release can trigger a chain of conversations that consumes far more time than the outage itself. The pharmaceutical industry page covers the broader regulatory context that shapes how these supply chains are run.

How should you actually think about recovery time?

Here is the practical reframe. Recovery time objective (RTO) is how quickly a system must be restored after a failure. Recovery point objective (RPO) is how much data you can afford to lose — the maximum gap between the last good capture and the failure. In most business contexts, RTO is the number people focus on, because the loss is productive time.

In this environment, the recovery point objective often matters more than recovery time, because data that was never captured cannot be recovered at all. You can restore a server in an hour, but if the environmental monitoring system was down for twenty minutes and no readings were taken during that window, those readings are gone. No restore brings them back. The gap is permanent, and quality has to disposition the batch against it.

What this implies is that monitoring and buffering need to happen at the instrument and system level, not only at the server level. A sensor that stores readings locally and syncs when connectivity returns preserves the record through a network outage. A LIMS that queues instrument data locally avoids a gap if the server is briefly unavailable. The design question is not "how fast can we recover the server" but "what captures the data while the server is down, and does quality accept that capture."

What does resilience look like here?

Concrete measures, not abstractions:

  • Redundancy where a gap is unrecoverable. If the loss of a single monitoring point creates an unrecoverable data gap, that point needs redundancy — a second sensor, a second path to the data store, or a local capture that survives a network failure.
  • Local buffering on monitoring systems. Instruments and building management systems that can store readings locally and forward them when the network or server returns, so a short outage does not create a permanent gap.
  • Tested restores rather than assumed backups. A backup that has never been restored is a hope, not a control. Test restores on a schedule, and document that the test happened and that the data came back intact.
  • Documented manual fallback procedures that quality has actually approved. If a system fails, there must be a written, quality-approved procedure for what operators do — take manual readings, log to paper, continue or pause. A procedure that quality has not reviewed is not a fallback; it is an improvised decision that will be scrutinized later.
  • Rehearsing the fallback rather than writing it and filing it. A manual procedure that has never been practiced will fail the first time it is used. A short tabletop — "environmental monitoring is down for 30 minutes, what do we do" — surfaces the gaps before an outage does.

Data protection and resilience in this environment is not a security add-on; it is a manufacturing control, and it should be specified with the same rigor as a process parameter.

What to ask your IT provider

  1. 1.What is our recovery point objective for each monitored system? Not "do we have backups" — how much data could we lose between the last capture and a failure, and is that acceptable to quality?
  2. 2.Which systems can buffer locally and for how long? If a system can store readings locally for hours, a short outage is recoverable. If it cannot, every outage is a potential gap.
  3. 3.When did we last test a restore of the batch record system? Ask for the date and the result. If the answer is "we back up nightly," that is not the same as "we can restore."
  4. 4.What is the documented manual procedure if environmental monitoring drops, and has quality approved it? If no such procedure exists, the fallback is improvisation. If it exists but quality has not seen it, it will not survive scrutiny.
  5. 5.Who calls quality when a system fails, and how quickly? The trigger for a deviation is the failure, not the discovery of a gap weeks later. Someone must be responsible for notifying quality the moment a monitored system goes down.

What stops, what it triggers, and what reduces the risk

SystemWhat stopsRegulatory consequenceWhat reduces the risk
Environmental monitoringTemperature, humidity, pressure readings not capturedData gap; deviation; batch disposition questionLocal buffering; redundant sensors; manual reading procedure approved by quality
Batch record systemOperators cannot execute or record stepsProduction halt; potential batch impact; deviationPaper fallback approved by quality; local queueing; tested restore
LIMSInstrument data not received or recordedResults gaps; retesting; data integrity questionLocal instrument storage; queued sync; documented retest procedure
Warehouse managementMaterials cannot be received, sampled, or releasedMaterial hold; components cannot be issuedManual log with quality review; reconciliation on restore
Serialization / track-and-tracePackaging line stops; data cannot be exchangedShipment cannot be released to commerceBuffering at the line level; manual reconciliation; tested integration
Access controlBadge readers fail; entry not loggedSecurity and safety question; controlled-area access uncontrolledManual sign-in with security review; physical override with documented entry
Cold chain monitoringTemperature data gap for stored or shipped productProduct quality question; potential loss of materialRedundant monitoring; local data loggers; manual temperature checks
Release testing systemsLaboratory cannot release resultsShipment holds; supply delayPrioritized recovery; manual result entry with review; tested restore

The recovery-point question

Most companies plan for how fast they can restart. The harder question is how much of the record they lost while they were down, because nothing restores that. A server comes back in an hour. A gap where no reading was taken does not come back at all — it becomes a deviation, an investigation, and a disposition decision that someone in quality has to make and defend. The companies that handle outages well are the ones that designed for the gap before it happened: local capture, quality-approved fallback, and the discipline to know that the record is the product.


Photo by TECNIC Bioprocess Solutions on Unsplash.

Frequently asked questions

Don't see your question? Email info@isectra.com and we'll answer it directly.

Share
Pharmaceutical
Santiago Aristizabal
President & COOSantiago Aristizabal

Santiago runs IT environments for pharmaceutical manufacturers. He writes for COOs and CFOs who have asked for an uptime number and received a percentage that tells them nothing about what actually breaks.

Get the next post in your inbox.

Signal, once or twice a month. No spam — just the posts worth reading.

Let's see what your IT could feel like.

A senior engineer will review your environment and respond within 24 hours. No sales script, no obligation.

(845) 563-0346
Call